Key Facts

PIPS Key Facts
Active Substance
Active Substance:
  • Synthetic Hypericin
Invented Name
PIP Number MHRA-100142-PIP01-21
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Ointment
Therapeutic area
Therapeutic area:
  • Oncology
Conditions / Indications
Conditions / Indications:
  • Treatment of cutaneous T-cell lymphoma
Route(s) of administration
Route(s) of administration:
  • Topical use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Synthetic Hypericin.pdf
Published Date 17/12/2021